Health-related quality of life and lived experiences in males and females with thoracic aortic disease and their partners by Thijssen, C.G.E. et al.
Open access 
  1Thijssen CGE, et al. Open Heart 2020;7:e001419. doi:10.1136/openhrt-2020-001419
To cite: Thijssen CGE, Dekker S, 
Bons LR, et al. Health- related 
quality of life and lived 
experiences in males and 
females with thoracic aortic 
disease and their partners. Open 
Heart 2020;7:e001419. 
doi:10.1136/
openhrt-2020-001419
CGET and SD contributed 
equally.
EG and JWR- H contributed 
equally.
Received 14 August 2020
Revised 3 September 2020
Accepted 3 September 2020
For numbered affiliations see 
end of article.
Correspondence to
Dr Jolien W Roos- Hesselink;  j. 
roos@ erasmusmc. nl
Health- related quality of life and lived 
experiences in males and females with 
thoracic aortic disease and their partners
Carlijn G E Thijssen,1,2 Silvy Dekker,1 Lidia Rianne Bons,1 Arjen L Gökalp,3 
Robert M Kauling,1 Annemien E van den Bosch,1 
Judith Anne Adriane Ellen Cuypers,1 Elisabeth M W J Utens,4,5 
Roland R L van Kimmenade,1,2 Johanna J M Takkenberg,3 Leontien M H Roos,6 
Eva Goossens   ,7,8,9 Jolien W Roos- Hesselink   1
Aortic and vascular disease
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published 
by BMJ.
ABSTRACT
Objective Thoracic aortic disease (TAD) may have 
substantial impact on health- related quality of life 
(HRQOL). We described HRQOL in patients with TAD, 
cardiovascular screening participants and their partners; 
identified factors associated with HRQOL; and explored 
lived experiences and feelings of anxiety or depression 
using a mixed methods design.
Methods For this cross- sectional study, all consecutive 
patients visiting the TAD outpatient clinic (2017–2019) at 
our centre were asked to complete three questionnaires: 
the Short Form 36 (SF-36), the Hospital Anxiety and 
Depression Scale (HADS) and the Rotterdam Disease 
Specific Questionnaire (RDSQ). A subsample was invited 
for in- depth interviews.
Results In total, 261 participants were included: 
147 patients with TAD (thoracic aortic diameter ≥40 
mm; 54 females, 36.7%), 114 screening participants 
(cardiovascular family screening; 71 females, 62.3%) 
and 66 partners. Compared with the general population, 
patients with TAD showed markedly lower HRQOL, 
whereas screening participants’ HRQOL was less impaired. 
Female and younger participants scored significantly 
lower on the SF-36 and HADS compared with male and 
older participants. Smaller aortic diameter was associated 
with better RDSQ score, and previous aortic surgery 
was associated with higher HADS depression scores. 
Furthermore, partners scored significantly lower on 2/8 
SF-36 subdomains when compared with the general 
population. From 11 interviewees, determinants of 
psychological distress included coping strategies, impact 
on social and professional life, disease- related knowledge, 
state of aortic diameters and physical symptoms.
Conclusions Healthcare professionals must be aware 
of HRQOL impairments in patients with TAD, particularly 
in younger females. Moreover, attention for partners is 
needed. Coping strategies and communication within 
the family were found to be important factors influencing 
psychological distress, and might be valuable leads for 
counselling and HRQOL improvement in this population.
INTRODUCTION
Thoracic aortic disease (TAD), including 
thoracic aortic aneurysms and dissections, has 
Key questions
What is already known about this subject?
 ► Health- related quality of life (HRQOL) is known to 
be reduced in patients with thoracic aortic disease 
(TAD).
 ► Male- female- specific HRQOL, partners’ HRQOL and 
HRQOL of individuals who undergo family screening 
for TAD have not yet been investigated.
 ► Combined qualitative and quantitative (ie, mixed 
methods) research has been suggested to gain more 
specific insights into the impact of TAD on HRQOL.
What does this study add?
 ► This study showed that HRQOL in screening partic-
ipants is affected to a lesser extent compared with 
patients with confirmed thoracic aortic aneurysm. 
Especially female and younger patients showed 
lower HRQOL.
 ► Partners’ HRQOL was reduced compared with the 
general population.
 ► Thoracic aortic diameter and thoracic aortic surgery 
were found to be important factors, which negative-
ly influenced HRQOL.
 ► Interviewed patients experienced variable levels 
of psychological distress, which were triggered by 
the evolution of the aortic disease, level of disease- 
related knowledge, loss of identity, sports participa-
tion and vocational choice, physical complaints and 
communication within their family.
How might this impact on clinical practice?
 ► To provide the necessary guidance and counselling 
to patients, healthcare workers need to be aware of 
the significant HRQOL impairments and psychologi-
cal distress in this patient population, particularly in 
younger female patients.
 ► Adequate coping strategies and good communica-
tion styles within the family seem to be important 
factors for influencing psychological distress.
 ► In addition, more attention for partners of patients 
with TAD is clearly warranted.
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an estimated prevalence of 9/100 000 per year in females, 
and 16/100 000 per year in males.1 These patients are 
at risk of sudden cardiac death.2 An inherited pattern of 
TAD is found in about 20% of cases.3 Therefore, patients 
and family members are often included in genetic and 
cardiovascular screening programmes, and may face life-
long uncertainties.4
The scarce evidence on health- related quality of life 
(HRQOL) in patients with TAD showed suboptimal 
results.5 6 Most research has been performed in patients 
with hereditary thoracic aortic diseases (HTAD) such as 
Marfan syndrome and Loeys- Dietz syndrome. In patients 
with HTAD, HRQOL was reduced as compared with the 
general population, and comparable to other chronic 
diseases.7–10
To achieve HRQOL improvement, it is important to 
obtain more patient and disease- specific information 
on HRQOL and lived experiences. However, no studies 
to date have evaluated male- female- specific HRQOL in 
patients with TAD. Furthermore, the impact of the disease 
on HRQOL of partners of patients with TAD has not yet 
been investigated. It has been suggested that studies using 
disease- specific questionnaires and a combined quan-
titative and qualitative approach would provide better 
insight.6 Therefore, in addition to existing well- validated 
questionnaires, we developed a disease- specific question-
naire, and aimed to: 1) evaluate HRQOL, anxiety and 
depression in patients with TAD, screening participants 
and partners and compare this with the general popula-
tion, 2) compare HRQOL between males and females, 3) 
identify factors associated with HRQOL and 4) explore 
lived experiences of patients with TAD and their feelings 
of anxiety or depression.
METHODS
Study populations
All consecutive patients who visited the specialised TAD 
outpatient clinic of our tertiary care centre between 
October 2017 and July 2019, were eligible for inclusion. 
The TAD outpatient clinic is a specialised outpatient clinic 
in which patients are seen by cardiologists or physician 
assistants for cardiovascular family screening or aortic 
surveillance, including referral from primary care and 
secondary care. Inclusion criteria were: adult age (≥18 
years), outpatient clinic visit for cardiovascular (family) 
screening or follow- up of TAD. Exclusion criteria were 
intellectual disability or language barrier. All eligible 
patients were invited to participate in the study, reasons 
for exclusion or failure to complete the questionnaires 
are shown in figure 1. Included participants were divided 
into two groups: participants with a (genetic) predispo-
sition and/or positive family history of TAD, hereafter 
referred to as ‘screening participants’; and ‘patients with 
TAD’ under surveillance for confirmed thoracic aortic 
aneurysm defined as a thoracic aortic diameter of ≥40 
mm.
Data collection
All included patients completed three questionnaires: the 
Short Form 36 (SF-36), the Hospital Anxiety and Depres-
sion Scale (HADS) and the Rotterdam Disease Specific 
Questionnaire for TAD (RDSQ), which was developed for 
this study. The questionnaires were distributed 1–2 weeks 
before the scheduled outpatient visit. Partners were asked 
to complete the same set of questionnaires either during 
the outpatient clinic visit or via email. All questionnaires 
were documented using a secured web- based applica-
tion for distribution of questionnaires during clinical 
research (GEneric Medical Survey Tracker, Erasmus MC 
and Equipe Zorgbedrijven, latest release 2019, V.1.8.6, 
open source). This application did not allow any missing 
answers. Patients who did not complete all three ques-
tionnaires were excluded. Additional data were collected 
from the patient files using a standardised case report 
form. Body surface area (BSA) was calculated using the 
DuBois and DuBois formula.11
FIGURE 1. Flowchart of patient inclusion 
 
Patients received questionnaires 
(n=459) 
Exclusion criteria: 
- Language barrier (n=12) 
- Visit for other reason (n=7) 
- Intellectual disability (n=6) 
Reasons for failure to complete 
questionnaires: 
- Did not complete all three 
questionnaires in time (n=65) 
- Unknown (n=62) 
- No specific reason (n=35) 
- Questionnaires caused stress or 
anxiety (n=15) 
- Other (n=14) 
- No priority / no time to complete 
the questionnaires (n=7) 
In-depth interviews (n=11) 
• Sex 
• Hereditary thoracic aortic 
disease (genetic mutation) 
• Previous aortic surgery 
• HADS score 
• RDSQ score 
Patients visiting the outpatient clinic 
(n=484) 
TAD patients= Patients with confirmed thoracic aortic aneurysm ≥ 40 mm; HADS = Hospital Anxiety and Depression Scale; RDSQ= Rotterdam 
Disease Specific Questionnaire. 
Patients with TAD  
(n=147) 
Partners 
(n=46) 
Screening participants 
(n=114) 
Partners 
(n=20) 
Patients included 
(n=261) 
Figure 1 Flow chart of patient inclusion. HADS, Hospital 
Anxiety and Depression Scale; RDSQ, Rotterdam Disease 
Specific Questionnaire; TAD, thoracic aortic aneurysm ≥40 
mm.
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Questionnaires
The SF-36 questionnaire is a widely used HRQOL ques-
tionnaire with 36 items, which has eight domains: Phys-
ical Functioning (PF), Role limitations due to Physical 
health problems (RP), Bodily Pain (BP), General Health 
perceptions (GH), Vitality (VT), Social Functioning (SF), 
Role limitations due to Emotional problems (RE) and 
general Mental Health (psychological distress) (MH).12 13 
The first four domains (PF, RP, BP and GH) together 
form the Physical Component Summary (PCS) and the 
last four domains (VT, SF, RE and MH) form the Mental 
Component Summary (MCS). All SF-36 subdomains have 
a score range of 0–100, with higher scores reflecting a 
better quality of life. The SF-36 has been translated and 
validated in the Dutch language.12 Male and female SF-36 
scores of participants were compared with male- female- 
specific norm values.12 Unfortunately, no age- specific 
norm values were available for males and females sepa-
rately. Therefore, an additional analysis was performed to 
compare participants with an age- matched general Dutch 
population.12 Likewise, SF-36 scores of partners were 
compared with the general population. Male- female- 
specific PCS and MCS were calculated using the mean 
and SD of the general Dutch population.
The HADS questionnaire assesses signs of anxiety 
and depression, and has been validated in the Dutch 
language.14 This 14- item scale is divided in two dimen-
sions: anxiety (seven items) and depression (seven items). 
The responses result in a score for each dimension with a 
score range of 0–21 and a total overall score with a score 
range of 0–42. Higher scores represent higher levels 
of anxiety and depression. A score of ≥8 on the HADS 
anxiety and depression subscales is internationally used 
as the cut- off score to define elevated levels of anxiety/
depression.15 HADS scores of participants were compared 
with age- matched norm values.14
The RDSQ for TAD was developed by a multidisci-
plinary team in our centre, including a cardiologist, 
psychologist, PhD candidate and physician assistant 
(online supplemental file 1).10 16 The purpose of this 
disease- specific questionnaire was to assess the impact of 
having TAD on daily life factors, such as: employment; 
family life; sexual functioning and sports participation. 
The questionnaire contains 18 statements which partic-
ipants were asked to rate on a 10- point Likert scale. A 
higher score reflects better agreement with the state-
ments, and more impaired TAD- related quality of life.
In-depth interviews
Eleven participants were purposively selected by an 
independent researcher based on differences in age, 
sex, genetic disorder, previous surgery, symptoms of 
depression and anxiety (HADS score) and RDSQ score 
(figure 1), in order to create a heterogeneous group. 
They were invited for a semi- structured qualitative inter-
view using a topic list, which evolved over the course of 
the study as an iterative process. Interviews were audio- 
taped using a voice recorder and non- verbal signs were 
noted. A verbatim transcript of the interviews was made 
on the same day.
The verbatim transcripts were analysed using content 
analysis, applying a multistep consecutive approach 
starting with an initial open coding phase, followed 
by axial coding and finishing with a selective coding 
process.17 In addition to the interviewer (SD), two other 
researchers (CGET and EG) read the interview tran-
scripts, and the individual narrative of each participant 
was constructed (ie, open coding). In the second phase, 
these researchers independently coded the individual 
narratives to identify significant and common aspects 
(ie, axial coding). When necessary, decisions were made 
in consensus. In a third phase, SD and EG analysed the 
codes together to construct the narrative syntheses (ie, 
selective coding) and the final coding tree, including 
an overview of the most important factors. The coding 
process was carried out using the NVIVO V.12 plus soft-
ware (QSR International, March 2018).
Statistical analysis
Data were analysed using SPSS statistics (IBM SPSS Statis-
tics V.25). Continuous data were presented as mean 
and SD when normally distributed, and as median with 
IQR when skewed. Categorical data were presented as 
frequencies with percentages. Comparison between 
patient and normative data was analysed using means 
and SD. Unpaired Student’s t- test or non- parametric 
Wilcoxon test were used to compare continuous varia-
bles, χ2 test or Fisher’s exact test were used to compare 
categorical variables. The one- sample Student’s t- test was 
used to compare norm- values with the study population 
means. Associations between baseline characteristics and 
RDSQ and HADS scores were evaluated using univariable 
linear regression models. Factors with a p value of <0.2 
and factors that were considered clinically relevant were 
considered for multivariable linear regression models. All 
models were adjusted for age and sex. Linear regression 
analyses were performed for screening participants and 
patients with TAD combined, and for partners separately. 
An α-value of <0.05 was considered significant. Bonfer-
roni correction for multiple testing was applied.
RESULTS
Patient population
Figure 1 shows a flow chart of the inclusion process. In 
total, 261 participants were included comprising 147 
patients with TAD (54 females, 36.7%) and 114 screening 
participants (71 females, 62.3%). Furthermore, 66 part-
ners completed the questionnaires. The partners’ sex was 
registered in 53 participants (80%), of which 63% was 
female.
Table 1 shows baseline characteristics of included males 
and females. Males showed significantly higher height, 
weight, BSA and absolute diameters of the thoracic aorta. 
Females showed higher adjusted ascending aortic diame-
ters (indexed for BSA). A significantly higher percentage 
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Table 1 Patient characteristics
Total (n=261) Interviews (n=11) P value Males (n=136) Females (n=125) P value
Age, years 52.9±15.8 55.5±14.2 0.588 53.7±15.9 52.1±15.7 0.407
Length, cm 177.2±14.7 178.0±8.5 0.853 184.0±13.9 169.7±11.7 <0.001
Weight, kg 83.9±19.4 84.5±16.5 0.923 92.2±17.9 75.3±17.1 <0.001
BSA, m2 2.0±0.2 2.0±0.2 0.794 2.1±0.2 1.9±0.2 <0.001
Hypertension 117 (44.8) 8 (72.7) 0.061 66 (48.5) 51 (40.8) 0.267
Hyperlipidemia 66 (25.3) 4 (36.4) 0.427 42 (30.9) 24 (19.2) 0.082
Smoking 25 (9.6) 0 (0.0) 0.347 10 (7.4) 15 (12.0) 0.25
Diabetes 9 (3.4) 0 (0.0) 0.523 5 (3.7) 4 (3.2) 0.833
Renal dysfunction 5 (1.9) 0 (0.0) 0.636 2 (1.5) 3 (2.4) 0.584
History of depression 16 (6.1) 1 (9.1) 0.673 2 (1.5) 14 (11.2) 0.001
History of anxiety disorder 4 (1.5) 1 (9.1) 0.037* 2 (1.5) 2 (1.6) 0.932
Beta- blocker use 60 (23.0) 5 (45.5) 0.075 35 (25.7) 25 (20.0) 0.271
ARB use 34 (13.0) 3 (27.3) 0.149 24 (17.6) 10 (8.0) 0.021
ACEi use 42 (16.1) 3 (27.3) 0.32 30 (22.1) 12 (9.6) 0.006
Diagnosis 0.314
  Marfan syndrome 10 (3.8) 1 (9.1) 7 (5.1) 3 (2.4) 0.267
  Loeys- Dietz syndrome 10 (3.8) 3 (27.3) 4 (2.9) 6 (4.8) 0.407
  Ehlers- Danlos syndrome 2 (0.8) 0 (0.0) 0 (0.0) 2 (1.6) 0.133
  Other 12 (4.6) 0 (0.0) 6 (4.4) 6 (4.8) 0.841
Confirmed genetic mutation 61 (23.4) 4 (36.4) 0.551 28 (20.6) 33 (26.4) 0.537
Positive family history aortic disease 132 (50.6) 6 (54.5) 0.818 64 (47.1) 68 (54.4) 0.489
Abdominal aortic aneurysm 9 (3.4) 2 (18.9) 0.006 8 (5.9) 1 (0.8) 0.025
Maximal diameter aortic root† 37.6±5.7 38.9±4.5 0.577 40.1±5.5 34.7±4.3 <0.001
Indexed diameter aortic root,† mm/BSA 19.0±2.9 23.5±13.9 0.303 18.7±2.4 19.0±2.7 0.395
Maximal diameter ascending aorta† 37.0±6.8 41.8±6.4 0.015* 38.4±6.6 35.7±7.0 0.004
Indexed diameter ascending aorta,† mm/BSA 18.7±3.9 20.8±3.5 0.06 17.9±3.3 19.5±4.2 0.003
Maximal diameter descending aorta† 27.1±6.3 27.6±3.2 0.819 28.0±6.2 25.2±6.2 0.004
Indexed diameter descending aorta,† mm/BSA 13.7±3.3 14.1±2.3 0.709 13.1±2.8 13.7±3.7 0.276
Previous aortic surgery 33 (12.6) 3 (27.3) 0.149 21 (15.4) 12 (9.6) 0.156
Previous dissection 23 (8.8) 1 (9.1) 0.97 9 (6.6) 14 (11.2) 0.192
Current partner 126 (48.3) 73 (53.7) 53 (42.4) 0.115
Current employment‡ 103 (39.5) 6 (54.5) 0.573 64 (47.1) 39 (31.2) 0.008
  Paid job 96 (36.8) 6 (54.5) 62 (45.6) 34 (27.2)
  Volunteer work 7 (2.7) 0 (0.0) 2 (1.5) 5 (4.0)
  Retired 57 (21.8) 3 (27.3) 28 (20.6) 29 (23.2)
  Student 16 (6.1) 0 (0.0) 7 (5.1) 9 (7.2)
  Unable to work/disabled 16 (6.1) 2 (18.2) 8 (5.9) 8 (6.4)
  Unemployed 12 (4.6) 1 (0.7) 11 (8.8)
Exercise 0.799 0.035
  Sports participation§ 105 (40.2) 4 (36.4) 63 (46.3) 42 (33.6)
  Walking or cycling 104 (39.8) 5 (45.5) 47 (34.6) 57 (45.6)
  None 36 (13.8) 2 (18.2) 18 (13.2) 18 (14.4)
Data are expressed as mean±SD or as absolute and percentage.
*Only patients without previous aortic surgery.
†Current employment=paid job or volunteer work.
‡Defined as: participating in any sport other than daily walking or cycling at any level at least once a week.
ACEi, ACE inhibitor; ARB, angiotensin II receptor blocker; BSA, body surface area.
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of males used ACE inhibitors (p=0.006) and angio-
tensin receptor blockers (ARBs) (p=0.021). Males were 
more often employed, and performed regular exercise 
more often, whereas females more often had a history 
of depression. Additionally, baseline characteristics 
between patients with TAD and screening participants 
were compared (online supplemental file 2).
Scores of patients with TAD and screening participants 
compared with the general population
Figure 2 shows comparison of SF-36 subscores of patients 
with TAD and screening participants with a sex- matched 
general population. Male screening participants showed a 
significantly higher score on the subdomain BP (77.3±22.7 
vs 86.3±19.5, p=0.004), whereas male patients with TAD 
showed significantly lower scores on PF (77.9±25.0 vs 
85.4±21.0, p=0.005), GH (54.0±23.1 vs 71.6±20.6, p<0.001) 
and VT (61.7±24.1 vs 71.9±18.3, p<0.001). Female screening 
participants showed a significantly lower score on GH 
(54.0±25.8 vs 69.9±20.6, p<0.001) and VT (54.8±26.4 vs 
64.3±19.7, p=0.003). Female patients with TAD showed 
significantly lower scores on all SF-36 subdomains except BP 
and MH when compared with the general population: PF 
64.7±26.3 vs 80.4±24.2, p≤0.001; RP 46.3±42.5 vs 73.8±38.5, 
p≤0.001; GH 49.0±21.9 vs 69.9±20.6, p≤0.001; VT 49.0±23.6 
vs 64.3±19.7, p≤0.001; SF 69.9±28.8 vs 82.0±23.5, p=0.003; 
RE 60.5±42.0 vs 78.5±35.7, p=0.003.
Figure 3 shows SF-36 scores of screening participants and 
patients with TAD compared with the age- matched general 
population. Younger patients with TAD and screening 
participants showed lower scores on all SF-36 subdomains, 
with increasing age this difference became smaller. HADS 
scores of patients with TAD and screening participants 
aged 18–65 years were not significantly different compared 
with the age- matched general population. Patients with 
TAD and screening participants older than 65 years showed 
lower scores when compared with the age- matched general 
population, especially on the HADS depression subdomain 
(2.9±3.7 vs 4.6±3.6, p=0.001).
Differences between HRQOL scores of males and females
Table 2 shows scores of male and female participants on 
subdomains of all questionnaires. Elevated scores (≥8) 
on the HADS anxiety subdomain occurred significantly 
more often in females (12.5% vs 29.6%, p=0.001).
Online supplemental file 3 shows stratified analysis 
of male- female HRQOL for screening participants and 
patients with TAD. Results were comparable to the 
unstratified analysis.
Online supplemental file 4 shows median scores of 
males and females on the RDSQ questionnaire. A signifi-
cant difference was found between males and females on 
question 13, which indicates whether the participant expe-
riences more anxiety than before the (potential) diagnosis 
of TAD (1.0 (IQR 1.0–3.0) vs 2.0 (IQR 1.0–5.0), p=0.011) 
and question 17 which indicates worries about the heredity 
of TAD (5.0 (IQR 2.0–8.0) vs 7.0 (IQR 5.0–9.0), p<0.001).
Health-related quality of life of partners
Table 3 shows the partners’ scores on all three question-
naires. Scores in partners were not significantly different 
compared with patients with TAD and screening partici-
pants. When compared with the general population, part-
ners showed significantly lower scores on 2/8 SF-36 subdo-
mains after Bonferroni correction: GH and VT. There were 
no significant differences in scores on the three question-
naires between partners of patients with TAD (n=46) and 
partners of screening participants (n=20).
Factors associated with HRQOL in patients with TAD, 
screening-participants and their partners
Multivariable analysis showed only history of anxiety 
disorder was associated with higher HADS anxiety score. 
Additionally, history of anxiety disorder, previous aortic 
Figure 2 Comparison of SF-36 scores of male and female 
participants with the general population. 1Significant 
difference between patients with TAD and the general 
population after Bonferroni correction. 2Significant difference 
between screening participants and the general population 
after Bonferroni correction. BP, Bodily Pain; GH, General 
Health; MH, Mental Health; PF, Physical Functioning; RP, 
Role Physical; RE, Role Emotional; SF-36, Short Form 36 
questionnaire; SF, Social Functioning; TAD, thoracic aortic 
disease; VT, Vitality.
Figure 3 Comparison of SF-36 scores of participants 
with age- matched general population. TAD, thoracic aortic 
disease, defined as confirmed thoracic aortic aneurysm of ≥ 
40 mm; SF-36, Short Form 36 questionnaire.
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surgery, diabetes and indexed descending aortic diam-
eter were found to be associated with higher HADS 
depression score. Higher RDSQ score was significantly 
associated with employment.
ARB use and history of aortic dissection in partici-
pants were associated with higher HADS anxiety scores 
in partners. Higher HADS depression scores of partners 
was associated with previous aortic surgery in the partic-
ipants. Higher RDSQ score of partners was found to be 
associated with history of aortic dissection in the partic-
ipants. The results of the univariable and multivariable 
analyses are displayed in online supplemental file 5.
In-depth interviews
Eleven participants (six females, mean age 57 years) were 
interviewed: four had a low scores; four had interme-
diate and three had high scores on the HADS and the 
RDSQ; four had known genetic mutations (Loeys- Dietz 
syndrome (n=3), Marfan syndrome (n=1)); five had 
familial TAD but no genetic diagnosis; three had already 
undergone aortic surgery, one had been accepted for 
surgery. Anxiety was not found to be a major topic in the 
interviews. Participants described a form of psychological 
distress related to having TAD and the risk of sudden 
events. Roughly, three groups could be distinguished, 
representing (almost) no psychological distress (n=5); 
moderate psychological distress (n=3) or prominent 
psychological distress (n=3). Among these groups there 
was great variability in the degree their daily life, person-
ality and professional career were affected. Several 
factors seemed to positively influence the level of psycho-
logical distress: disease- related communication with 
family members; level of the disease- related knowledge 
of the participant; evolution of the aortic disease (stable 
aortic diameter) and coping strategies such as expressing 
emotions and seeking emotional support. Factors that 
negatively influenced the level of distress were: physical 
complaints; sense of loss of identity due to the disease, 
including sports participation and choice of profession. 
Figure 4 was made to create an overview and shows which 
of these factors resulting from the coding tree were found 
to influence psychological distress the most. All partici-
pants had physical complaints such as thoracic pain, dysp-
noea or tachycardia causing psychological distress. Sense 
of loss of identity was found to be a trigger in a smaller 
number of participants. Regular controls and stable aortic 
diameters had a great positive influence on psychological 
distress for the majority of participants. Knowledge about 
the disease seemed to decrease distress, although some 
participants expressed becoming more distressed after 
knowing what could happen. The unpredictable and 
uncertain course of the disease triggered a certain loss 
of control and increased psychological distress in almost 
all participants. Lifestyle restrictions on physical activity 
Table 2 Male- female scores of participants on all questionnaires
Total (n=261) Males (n=136) Females (n=125) P value
RDSQ
  Total score 51 .0 (32.0–80.0) 48.0 (29.3–78.5) 53.0 (34.5–85.5) 0.160
SF-36
  Physical Functioning 85.0 (60.0–95.0) 95.0 (71.3–100.0) 80.0 (50.0–95.0) <0.001*
  Role Physical 100.0 (25.0–100.0) 100.0 (50.0–100.0) 75.0 (12.5–100.0) 0.024
  Bodily Pain 80.0 (57.5–100.0) 90.0 (67.5–100.0) 67.5 (45.0–100.0) <0.001*
  General Health 55.0 (40.0–100.0) 60.0 (40.0–80.0) 55.0 (35.0–70.0) 0.030
  Vitality 60.0 (40.0–80.0) 70.0 (50.0–83.8) 50.0 (35.0–75.0) <0.001*
  Social Functioning 87.5 (62.5–100.0) 100.0 (75.0–100.0) 75.0 (62.5–100.0) <0.001*
  Role Emotional 100.0 (66.7–100.0) 100.0 (100.0–100.0) 100.0 (33.3–100.0) <0.001*
  Mental health 80.0 (64.0–88.0) 84.0 (69.0–92.0) 76.0 (56.0–88.0) 0.007
  PCS 49.2 (38.2–55.8) 51.6 (41.8–56.3) 46.2 (35.4–54.5) 0.017
  MCS 51.9 (42.8–56.9) 54.4 (48.0–57.4) 48.5 (37.9–55.0) <0.001*
HADS
  Anxiety score 4.0 (2.0–7.0) 4.0 (2.0–6.0) 4.0 (2.0–8.0) 0.023
  Depression score 2.0 (1.0–5.0) 1.5 (0.0–4.8) 2.0 (1.0–5.0) 0.043
  Anxiety score ≥8 54 (20.7) 17 (12.5) 37 (29.6) 0.001*
  Depression score ≥8 39 (14.9) 16 (11.8) 23 (18.4) 0.133
  Total score 6.0 (3.0–12.0) 5.0 (2.3–10.0) 6.0 (4.0–15.5) 0.037
Data was non- parametrically distributed and therefore expressed as medians (IQR), or as absolute and percentage.
*Significant after Bonferroni correction.
HADS, Hospital Anxiety and Depression Scale; MCS, Mental Component Summary; Participants, screening participants and patients with 
thoracic aortic disease; PCS, Physical Component Summary; RDSQ, Rotterdam Disease Specific Questionnaire; SF-36, Short Form 36.
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and professional career were accepted by most of the 
participants. The majority (n=9) stated that their level 
of distress increased shortly prior to regular check- ups 
of the aortic diameter, and decreased again when the 
results showed a stable aortic diameter. Coping strategies 
seemed to influence all factors mentioned above. A more 
detailed description of the in- depth interviews results can 
be found in online supplemental file 6.
Table 3 Scores of partners compared with participants and with the general population
Partners
(n=66) Participants (n=261) P value General population P value
RDSQ
  Total score 49.5 (32.5–77.0) 51 .0 (32.0–80.0) 0.784
SF-36
  Physical Functioning 76.1±25.2 76.1±26.5 0.991 83.0±22.8 0.035
  Role Physical 65.6±41.1 67.4±4.6 0.748 76.4±36.3 0.044
  Bodily Pain 74.1±25.4 75.5±25.7 0.707 74.9±23.4 0.806
  General Health 55.8±21.8 55.4±24.4 0.902 70.7±20.7 <0.001*
  Vitality 60.1±23.4 59.0±25.1 0.768 68.6±19.3 0.006*
  Social Functioning 80.1±24.2 79.2±25.8 0.802 84.0±22.4 0.216
  Role Emotional 84.7±31.4 77.2±37.5 0.108 82.3±32.9 0.553
  Mental health 76.9±17.1 75.2±19.4 0.529 76.8±17.4 0.957
  PCS 45.5±11.5 46.4±11.5 0.568
  MCS 50.1±9.7 48.2±11.5 0.255
HADS
  Anxiety score 4.0 (2.0–6.0) 4.0 (2.0–7.0) 0.554
  Depression score 1.0 (0.0–4.0) 2.0 (1.0–5.0) 0.158
  Total score 5.5 (3.3–10.0) 6.0 (3.0–12.0) 0.112
Data are expressed as medians (IQR) when non- parametrically distributed. However, for comparison with the general population mean±SD 
was used.
*Significant after Bonferroni correction.
HADS, Hospital Anxiety and Depression Scale; MCS, Mental Component Summary; Participants, screening participants and patients with 
thoracic aortic disease; PCS, Physical Component Summary; RDSQ, Rotterdam Disease Specific Questionnaire; SF-36, Short Form 36.
Figure 4 The influence on psychological distress of factors described in the coding tree. Red circle=negative influence on 
psychological distress; green circle=positive influence on psychological distress. The size of the circles corresponds with the 
amount of participants in whom psychological distress was triggered by this factor. Depression can result from a large amount 
of psychological distress. Patients’ coping strategies regulate the effect of these factors.
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DISCUSSION
To our knowledge, this is the first study describing male- 
female- specific aspects of HRQOL in both screening 
participants and patients with TAD using a mixed 
methods approach. Male and female patients with TAD 
reported clearly impaired HRQOL compared with the 
general population, while screening participants were 
affected to a lesser extent. Moreover, female and younger 
participants showed the lowest HRQOL scores. HRQOL 
in partners was also found to be suboptimal, although 
less impaired than in patients with TAD. Additionally, 
level of anxiety in patients with TAD was not found to be a 
major topic in the in- depth interviews, participants rather 
described a form of psychological distress.
In this study, patients with TAD were found to have 
decreased HRQOL, coping problems and psychological 
distress, similar to the findings of Olsson et al and Connors 
et al.5 18 Additionally, we found HRQOL in screening 
participants was impaired, although to a lesser extent. We 
hypothesised that the risk of having TAD would equally 
impact screening participants compared with patients 
with TAD. However, having an aortic diameter ≥40 mm 
clearly had a more profound impact on HRQOL. This 
does not seem to result in clinically relevant levels of 
anxiety or depression, since HADS scores of patients with 
TAD were comparable to the general population. As has 
been reported before, most of our participants accepted 
restrictions on physical activity and employment as ‘part 
of life’.18
In the general population, HRQOL is known to decline 
with increasing age.12 We found a much less pronounced 
decline in patients with TAD. Presumably, the impact of 
having a serious disease with reduced life expectancy is 
more distinct at young age. In addition, we found less 
favourable scores, and more anxiety in females compared 
with males. This is also described in the general popu-
lation12 19 and in patients with heart disease as well as 
chronic kidney disease,20 21 but has not previously been 
reported in patients with TAD.6 Multiple studies reported 
these male- female differences were largely attributable 
to sociodemographic factors such as income, physical 
activity and marital status.22 23 This might also apply to our 
population, since employment status and physical activity 
were significantly different between males and females. 
However, this does not completely seem to explain male- 
female difference in HRQOL.23 Another potential expla-
nation might be that females experience their functional 
capacity and quality of life different from males, and this 
certainly needs more attention in future studies.
Partners’ HRQOL was also found to be affected, 
although to a lesser extent, and seemed to be negatively 
influenced by factors related to aortic events and disease 
progression in the participants. HADS anxiety scores 
in partners were associated with ARB use of the partic-
ipants. This may be due to the increased risk of aortic 
expansion and eventually dissection when hypertension 
persists. The need of antihypertensive medication might 
therefore cause more worries and anxiety in partners. 
The impact of TAD on partners has been underexposed, 
but might be very important, especially since interviewed 
participants reported that communication with their part-
ners and family about the disease was an important factor 
influencing their level of psychological distress. There-
fore, we believe the impact of the disease on the quality of 
life in partners should be assessed on a regular basis as it 
might impact the HRQOL of the patients. More research 
is needed to evaluate which factors are important and can 
be easily addressed. It is essential to involve partners in 
counselling and interventions for HRQOL improvement, 
and provide practical advice on coping with the disease 
for patients as well as their partners.
Goldfinger et al and Moon et al showed that daily 
life aspects such as employment or health insurance 
impacted HRQOL rather than disease- related factors.8 24 
In contrast, we found mainly disease- related factors, such 
as a history of aortic dissection or surgery and the diam-
eter of the aorta, to be associated with HRQOL. These 
factors emerged from results of both the quantitative and 
qualitative analyses. Potentially, this is due to the pres-
ence of a reliable social- security system in the Nether-
lands. Interviewed participants experienced the disease 
as a continuous threat, as was previously described in 
patients with abdominal aortic aneurysm.25 When looking 
into the RDSQ results in more detail, we noticed the 
highest scores were found on questions about heredity 
and surgery (online supplemental file 4), which indicates 
these factors warrant attention. Our findings emphasise 
the importance of expectation management and counsel-
ling regarding the disease course and treatment plan to 
the patient and their partner or family members, as well 
as providing clear and patient specific information about 
the disease and treatment options for shared decision 
making. Clinicians should be aware of HRQOL impair-
ments, anxiety and depression in patients with TAD and 
their partners, and systematic screening is mandatory. 
Several factors were identified which might improve 
HRQOL: employment of constructive coping strategies 
such as expressing one’s emotions, seeking emotional 
support, grieving loss of one’s identity; and good commu-
nication within the family. When indicated, psycholog-
ical support should be offered. More research is needed 
to evaluate the potential positive effect of psychological 
support and counselling in these patients.
Limitations
In this study, we used three (digital) questionnaires 
to measure self- reported quality of life. Two are well- 
known validated questionnaires, the RDSQ question-
naire, however, was newly developed and used in one 
previous study so far.10 Its psychometric properties have 
to be further evaluated. Therefore, results of this ques-
tionnaire are to be interpreted with caution. The SF-36 
is more suited to assess overall HRQOL and the HADS 
was used for detecting clinically relevant anxiety and 
depression. With the addition of the RDSQ, especially 
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when combined with the results from the in- depth inter-
views, we were able to identify specific disease- related 
factors influencing HRQOL in this population. The 
overall response rate of patients participating in this 
study was 57%, which is comparable to other (online) 
surveys.26 In order to provide insight into potential selec-
tion bias, the selection process is represented in figure 1. 
Although some bias cannot be ruled out, we expect to 
have included a representative sample. The number of 
partners included was limited (25%). Not all patients had 
a partner, but still this number is relatively low and better 
coverage of the partners is important for future research.
CONCLUSIONS
HRQOL of patients with TAD was found to be impaired, 
most significantly in younger females. Previous aortic 
surgery, aortic dissection and larger diameter of the aorta 
were found to be associated with impaired HRQOL. Part-
ners’ HRQOL was also reduced, warranting further atten-
tion. Patients with TAD and partners should be systemat-
ically screened for symptoms of depression and anxiety, 
and when indicated psychological support should be 
offered. Counselling patients to employ constructive 
coping strategies and good communication within the 
family might reduce psychological distress and improve 
HRQOL in this population.
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